I've been going over the old announcements here and it should only be a matter of months before we see the first decent sales come through the pipeline here. imv this company has a huge future, and we know what the backers are able to do with price. they have ticked all the boxes and will soon get it running. quietly accumulating ... as others obviously are and will expect one or two more big announcements to trigger the buying ... first stop .07 to shake the stale holders, then .10 not far away. the resmed execs now on board will have the contacts to ensure this technology gets into the hands of those who can push it best.
to recap the past four months -----
15/04/2010 KSX Signs Distribution Agreements in the United States 08/04/2010 European CE Mark granted to KarmelSonix` WHolter Device 18/02/2010 KarmelSonix Signs Agreement with Second Distributor in India 16/02/2010 KarmelSonix Expands Senior Sales and Marketing Team 18/12/2009 Clinical Study Accepted for Publication in Asthma Journal 10/12/2009 KSX Announces Australian Pharmacy Distribution Agreement 09/12/2009 Successful Placement of Shares Raises Approx. $4.5m 03/12/2009 KSX secures first substantial order from India 17/11/2009 ACCP Applies for WheezeRate CPT Reimbursement Code 16/11/2009 KarmelSonix Expands European Distribution Channels 10/11/2009 Personal WheezoMeter adopted by ALMS Doctors 13/10/2009 WheezoMeter and PulmoTrack Granted Health Canada Licensing 24/09/2009 WheezoMeter Granted FDA Clearance 01/09/2009 KSX Signs First Private Health Fund Agreement in Australia
KSX Price at posting:
2.8¢ Sentiment: Buy Disclosure: Held